title: Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation.
authors.forename: E
authors.initials: E
authors.lastname: Rettinger
authors.forename: H
authors.initials: H
authors.lastname: Bonig
authors.forename: S
authors.initials: S
authors.lastname: Wehner
authors.forename: G
authors.initials: G
authors.lastname: Lucchini
authors.forename: A
authors.initials: A
authors.lastname: Willasch
authors.forename: A
authors.initials: A
authors.lastname: Jarisch
authors.forename: J
authors.initials: J
authors.lastname: Soerensen
authors.forename: R
authors.initials: R
authors.lastname: Esser
authors.forename: C
authors.initials: C
authors.lastname: Rossig
authors.forename: T
authors.initials: T
authors.lastname: Klingebiel
authors.forename: P
authors.initials: P
authors.lastname: Bader
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005240:Feasibility Studies; D006801:Humans; D019409:Interleukin-15 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology / Q000637:transplantation*; D033581:Stem Cell Transplantation / Q000379:methods*
chemical_list: D019409:Interleukin-15